Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

bcr genes and transcripts.

B Lifshitz1, E Fainstein, C Marcelle

  • 1Department of Chemical Immunology, Weizmann Institute of Science, Rehovot, Israel.

Oncogene
|February 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

TCTP as a therapeutic target in melanoma treatment.

British journal of cancer·2017
Same author

The association between the signalment, common causes of canine otitis externa and pathogens.

The Journal of small animal practice·2011
Same author

Exosome secretion, including the DNA damage-induced p53-dependent secretory pathway, is severely compromised in TSAP6/Steap3-null mice.

Cell death and differentiation·2008
Same author

TCTP protects from apoptotic cell death by antagonizing bax function.

Cell death and differentiation·2008
Same author

ALL-1/MLL1, a homologue of Drosophila TRITHORAX, modifies chromatin and is directly involved in infant acute leukaemia.

British journal of cancer·2004
Same author

Expression profiles of acute lymphoblastic and myeloblastic leukemias with ALL-1 rearrangements.

Proceedings of the National Academy of Sciences of the United States of America·2003

Researchers cloned and characterized the normal breakpoint cluster region (bcr) gene, crucial for understanding chronic myelogenous leukemia (CML) development. This study details the bcr gene

Area of Science:

  • Molecular Biology
  • Genetics
  • Oncology

Background:

  • Human chronic myelogenous leukemia (CML) is a clonal hematologic disorder.
  • CML is characterized by the t(9:22) chromosome translocation, creating the bcr-abl fusion gene.
  • The bcr-abl oncogene is central to CML pathogenesis.

Purpose of the Study:

  • To clone and characterize the complementary DNA (cDNA) of the normal breakpoint cluster region (bcr) gene.
  • To investigate the transcriptional regulation and expression of the bcr gene.
  • To understand the genomic organization of bcr and related genes.

Main Methods:

  • cDNA cloning and characterization.
  • Sequence analysis of the bcr gene and its transcripts.
  • Identification of regulatory elements and gene duplication events.

Related Experiment Videos

Main Results:

  • The normal bcr gene encodes a protein of 1271 amino acids.
  • GC-rich motifs upstream of the open reading frame suggest roles in bcr transcription initiation.
  • Ubiquitous expression of 7.0 and 4.5 kb bcr transcripts was observed across examined cell types.
  • The 5' untranslated region of bcr is incorporated into the CML-specific bcr-abl mRNA.
  • Three bcr-related genes, likely products of gene duplication, were identified in the human genome.

Conclusions:

  • The characterization of the normal bcr gene provides a foundation for understanding CML.
  • The identified regulatory elements offer insights into bcr gene expression control.
  • The presence of bcr-related genes suggests an evolutionary pathway involving gene duplication.